Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

From complexity to simplicity: The new era of plate readers

In this interview with NewsMedical, Dr. Yousef Nazirizadeh offers insights into the advanced functionalities and diverse types of Byonoy's plate readers, underscoring their significance in the industry.

From Byonoy 12 Dec 2023

How to optimize nuclei extraction & counting for single cell sequencing

In this interview, News Medical talks to DeNovix about the best way to prepare nuclei samples before single cell sequencing workflows and optimize nuclei extraction.

From DeNovix Inc. 1 Nov 2023

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

In the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the incredible potential of mass spectrometry proteomics in biomedical research.

From Bruker Life Sciences Mass Spectrometry 27 Oct 2023

Sphere Fluidics' Expansion and Vision

In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics' new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.

From Sphere Fluidics 25 Oct 2023

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.

From Sino Biological Inc. 24 Oct 2023

Common challenges when seeking market access for rare disease therapies

In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth & Strategy at AscellaHealth about the recurring challenges met when seeking market access for rare disease therapies.

From AscellaHealth, LLC. 19 Oct 2023

Recent Advancements in Cell Based Therapy

In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.

From MaxCyte, Inc. 11 Oct 2023

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

We spoke to Professor Janet Hemingway, founding Director of iiCON and Professor of Tropical Medicine at Liverpool School of Tropical Medicine.

From ELRIG (UK) Ltd. 9 Oct 2023

Arrayed CRISPR Screening for Revolutionizing Target Discovery

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Kuenzel, Associate Director in the Functional Genomics department at AstraZeneca about the application of arrayed CRISPR screening for target identification and more.

From Society for Laboratory Automation and Screening (SLAS) 27 Sep 2023

Atellica Solution Portfolio: Engineering predictability in a highly unpredictable lab environment

In this interview, News Med talks to Lisa Cratty about the unpredictable lab environment and engineering predictability.

From Siemens Healthineers 22 Sep 2023

Innovations in baculovirus–insect cell expression systems

The baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus expression vector system (BEVS)— remains a crucial technology for manufacturing large and complex proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product design, and versatility for a broad range of proteins.

From Sino Biological Inc. 20 Sep 2023

Compound Management and its Crucial Role in Early Pharmaceutical Research

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro about his research, as well as the role of compound management in pharmaceutical research.

From Society for Laboratory Automation and Screening (SLAS) 7 Sep 2023

Biosciences: how nature is changing the future of drug discovery

In this new podcast, Bruker's Kate Stumpo talks with Enveda's Pelle Simpson on the opportunities of natural products in the field of multiomics.

From Bruker Life Sciences Mass Spectrometry 6 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

Big Tuna and automated buffer exchange: An interview with Unchained Labs

In this interview, AZoNetwork speaks with Joe Barco, the Senior Director of Workflow Marketing at Unchained Labs, about the benefits of automated buffer exchange with Big Tuna.

From Unchained Labs 4 Sep 2023

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.

From Rapid Novor Inc 23 Aug 2023

Ensuring colony counts remain precise and verifiable using a completely automated colony counting system

In this interview, NewsMedical speaks with Richard Edridge, Synbiosis Projects and Sales Manager for Synoptics, about AutoCOL, a completely automated colony counting system for fully traceable colony counts with every use.

From Synoptics Ltd 10 Aug 2023

Medical grade adhesives for medical device manufacturing

In this interview, Master Bond describes the features and benefits of medical grade adhesives for medical device manufacturing.

From Master Bond Inc. 8 Aug 2023

Pharmatech: The Art of AI-Driven Drug Design with Exscientia

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Garry Pairaudeau, Chief Technology Officer at Exscientia, about pharmatech, AI, and more.

From Society for Laboratory Automation and Screening (SLAS) 3 Aug 2023

Realizing the Potential of Vendor Engagement

In this interview conducted in anticipation of ELRIG's Drug Discovery 2023 Conference, we spoke to Nick Clare, Vendor Strategy Work Group Lead for ELRIG, about what vendors can gain from attending ELRIG events, such as Drug Discovery 2023.

From ELRIG (UK) Ltd. 21 Jul 2023